You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III salivary gland cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +4 more
  • New York, New York
    Memorial Sloane Kettering Cancer Center
Jan 11, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +5 more
  • Pembrolizumab
  • Pemetrexed Disodium
  • Scottsdale, Arizona
  • +2 more
Mar 15, 2022

GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

Not yet recruiting
  • Salivary Gland Cancer
  • Observation
  • (no location specified)
Oct 13, 2023

Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)

Not yet recruiting
  • Gland
  • Salivary Gland Cancers
  • Sacituzumab Govitecan
  • Houston, Texas
    M D Anderson Cancer Center
May 22, 2023

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

Recruiting
  • Salivary Gland Cancer
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Oct 27, 2022

Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

Recruiting
  • Salivary Gland Carcinoma
  • Chicago, Illinois
  • +6 more
Sep 22, 2022

PSMA-PET Imaging of Salivary Gland Tumours and Other Rare

Recruiting
  • Salivary Gland Tumor
  • Rare Malignant Neoplasm
  • 68-Ga PSMA PET scan
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 11, 2022

Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

Recruiting
  • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2023

Salivary Gland Cancer, HER2 Gene Mutation Trial in Boston (Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy,

Recruiting
  • Salivary Gland Cancer
  • HER2 Gene Mutation
  • Ado-trastuzumab (T) emtansine (T-DM1)
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 2, 2023

Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

Not yet recruiting
  • Salivary Gland Cancer
  • vedicitumomab (Edisil, RC48）
  • +3 more
  • (no location specified)
Jun 9, 2023

Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

Recruiting
  • Salivary Gland Cancer
  • Nagoya, Aichi, Japan
  • +11 more
Jan 21, 2023

Salivary Gland Cancer, Salivary Gland Tumors Trial in Novi Sad (Surgical intervention with or without postoperative adjuvant

Completed
  • Salivary Gland Cancer
  • Salivary Gland Neoplasms
  • Surgical intervention with or without postoperative adjuvant therapy
  • Novi Sad, Serbia
    Clinic for maxillofacial surgery Clinical center of Vojvodina
May 22, 2022

Xerostomia Due to Hyposecretion of Salivary Gland Trial in Cairo (Chamomile, Saline mouthwash)

Completed
  • Xerostomia Due to Hyposecretion of Salivary Gland
  • Chamomile
  • Saline mouthwash
  • Cairo, Egypt
    Ain Shams University
Nov 1, 2023

Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

Withdrawn
  • Salivary Gland Carcinoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 5, 2022

Head Neck Cancer Trial in Groningen (Submandibular Gland Stem Cell Transplantation)

Recruiting
  • Head and Neck Cancer
  • Submandibular Gland Stem Cell Transplantation
  • Groningen, Netherlands
    UMCG
May 24, 2022

Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)

Recruiting
  • Adenoid Cystic Carcinoma
  • Salivary Gland Cancer
  • Miami, Florida
  • +7 more
Oct 26, 2022

Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)

Recruiting
  • Malignant Salivary Gland Cancer
  • Salivary Gland Cancer
  • Tampa, Florida
  • +2 more
Feb 10, 2022

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • +25 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Torrance, California
  • +6 more
Jan 12, 2023

Thyroid Cancer, Salivary Gland Cancer Trial in Chicago (Pembrolizumab, Docetaxel)

Recruiting
  • Thyroid Cancer
  • Salivary Gland Cancer
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Apr 13, 2022

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • Duarte, California
  • +9 more
Nov 15, 2022

Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)

Recruiting
  • Salivary Gland Cancer
  • Salivary Duct Carcinoma
  • 68Ga-PSMA-PET/CT
  • 18FDG-PET/CT
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 15, 2022